Subscribe to Search results

The Scottish Expert Group on Financial and Other Support was set up to look at the pros and cons of a system of financial and other support for those harmed by health service treatment where the NHS was not at fault.

Published on:

A disagreement began between the UK Government and Scottish Executive as to whether making payments to relieve financial hardship out of health care treatment was something that the Scottish Executive had a right to legislate on. Malcolm Chisholm said that the advice he had was that this was a devolved matter but he was not sure this was right.

Published on:

The Secretary of State wrote to Malcolm Chisholm informing him that an ex gratia payment scheme for people in Scotland who had been infected with Hepatitis C as a result of treatment with NHS blood/blood products would be accepted as falling within devolved competence.

Published on:

A document relating to spontaneous clearance of Hepatitis C suggested press lines to be adopted, including "Ministers have made it clear from the outset that the scheme would only make payments to patients who had experienced lasting physiological harm as a result of their infection."

Published on:

Further nominees for expert groups put forward

Published on:

"The surveillance of transfusion-associated viral hepatitis" was published in the Journal of the American Medical Association. The article supported Dr Allen's striking "ten times" finding.

Published on:

In his book "The Gift Relationship", Professor Richard Titmuss commented on the additional risk created by paid donations mixed in commercial pools in the US.

Published on:

Dr Craske linked the risks of commercial concentrates from large pools with domestic production.

Published on:

A letter from Dr Garrott Allen to Dr Maycock emphasised the risks associated with commercial blood in a mixed combination to bring up an astounding attack rate from one that was relatively unnoticed.

Published on:

Dr Maycock knew the risks associated with commercial blood in a mixed combination to bring up an astounding attack rate; possibly Dr Owen knew of this too.

Published on:

In a Blood Money interview, Dr Craske explained the risk of larger pools, acknowledging that one donor could affect a pool and that Factor 8 should only be used in emergencies and by qualified staff.

Published on:

Dr Owen acknowledged that it was likely that he would have read Craske's article, acknowledging the risks of commercial concentrates from large pools with domestic production.

Published on:

Professor Manucci pointed out that strict adherence to the "small pool concept" in Sweden had given rise to "a very low incidence" of post-transfusion hepatitis in people with Haemophilia B, and suggested that the adoption of such a concept would be "a significant step forward".

Published on:

The Council of Europe recommended that blood collection agencies and pharmaceutical companies should give treating physicians and consumers detailed information about blood and blood related products, including the nature of the donor pool from which the products were derived.

Published on:

Dr James Smith at PFL asked Dr Lane, as the director of BPL, to agree to his increasing the pool size used to 900kg-1,000kg of plasma (roughly 4,500-5,000 donations).

Published on:

Dr Lane observed that once one had exceeded the 100kg-200kg pool size, one had already exceeded any possibility of small pool protection.

Published on:

Dr Craske felt that the increased usage of small pooled concentrates would help to reduce the incidence of hepatitis in the haemophilic population.

Published on:

Dr Smith sent a memo to Dr Lane, suggesting that three tables in a report by Dr Craske, which he had presented to the working party, "offer good ammunition against the importation of U.S. plasma or its products".

Published on:

Dr Peter Foster and Ida Dickson considered that losses in Factor 8 from having to meet quality control requirements could be reduced.

Published on:

A memo from Dr Foster to John Watt and others described the specifics of a new-scale thawing tank becoming ready for use at the start of 1981.

Published on: